Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Pace of Designer Drugs Increases Year on Year

Published: Monday, August 12, 2013
Last Updated: Monday, August 12, 2013
Bookmark and Share
Science needs to work hard to keep pace with clandestine designer drugs labs – that was the hard-hitting message delivered to delegates at AACC Clinical Lab Expo.

Leading testing firm, Randox Toxicology highlighted the problem and outlined the requirement for a rapid and comprehensive designer drugs testing system to tackle the issue. In recent years there has been a significant increase in new ‘designer drugs,’ also known as legal highs or bath salts. UN Drugs and Crime Office reported recently that member states have experienced a rise in numbers by more than 50 per cent in less than three years to 251 new designer drugs by mid-2012.

Speaking after addressing delegates, Randox Toxicology’s R&D team leader Dr Joanne Darragh said, “The current most prolific designer substances are synthetic cannabinoids (K2 and SPICE) and the synthetic cathinones, commonly referred to as ‘Bath Salts’ mirroring to a large extent the effects of the most popular traditional drugs. A recent development, however, is an increasing proportion of substances reported that are from less known and more obscure chemical groups. These compounds are often not detected among users who undergo regular drug screening due to the absence of a wider screening methodology.”

Randox Toxicology have developed the most rapid and comprehensive designer drug test in the world, as Dr Darragh further explained,

“Randox’s unique multiplex system allows us to detect 110 designer drugs, from one blood or urine sample.

“There is also a growing trend coming from the labs creating designer drugs to modify the molecular structure in order to navigate national and international bans. Development of new antibodies means that Randox Toxicology have the capability to rapidly meet changing trends in designer drug use, in fact, we can adapt our technology to test for new or modified drugs quicker than any other supplier in the world.”

“Thanks to Randox’s revolutionary biochip array technology, we can adapt any test in a completely unique and accurate way to produce the quickest result.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,600+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Rates of Nonmedical Prescription Opioid Use Disorder Double in 10 Years
Researchers at NIH have found that the nonmedical use of prescription opioids has more than doubled among adults in the United States from 2001-2002 to 2012-2013.
Self-Assembling Protein Shell for Drug Delivery
Made-to-order nano-cages open possibilities of shipping cargo into living cells or fashioning small chemical reactors.
Guided Chemotherapy Missiles
Latching chemotherapy drugs onto proteins that seek out tumors could provide a new way of treating tumors in the brain or with limited blood supply that are hard to reach with traditional chemotherapy.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
‘Human-on-a-Chip’ Could Replace Animal Testing
Researchers are developing a “human-on-a-chip,” a miniature external replication of the human body, integrating biology and engineering with a combination of microfluidics and multi-electrode arrays.
A New Approach to Chemical Synthesis
Communesins, originally found in fungus, could hold potential as cancer drugs.
‘Missing Tooth’ Hydrogels Handle Hard-to-Deliver Drugs
Rice University’s custom hydrogel traps water-avoiding molecules for slow delivery.
Copper is Key in Burning Fat
Berkeley Lab scientist says results could provide new target for obesity research.
Better Animal Model to Improve HIV Vaccine Development
Penn study identifies a new tool to produce better HIV vaccine designs.
Identifying Side-Effects At Early Stages Of Drug Development
An approach that could reduce the chances of drugs failing during the later stages of clinical trials has been demonstrated by a collaboration between the University of Cambridge and pharmaceutical company GlaxoSmithKline (GSK).
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!